This is service for phase 1/phase 2 open label trial of a novel indenoisoquinolone cmyc/topoisomerase 1 inhibitor (LMP744) in recurrent glioblastoma. POP: 02/06/2026 to 02/05/2027.
Active Purchase Order Awarded Last action
- Contract number
- 75N95A26P00038
- Awardee
-
Medical Research Support LLC UEI Y5JMG3517VM7
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $21,450
Award facts
- Contract value 100% obligated
- $21,450.00 Current and potential, with all options
- Completion date 73% complete
- Current and potential, with all options
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Gaithersburg, MD 20878, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $21,450 firm fixed-price purchase order to Medical Research Support LLC, a women-owned small business based in North Potomac, Maryland, for clinical research support services. The contract, which runs from February 6, 2026 through February 5, 2027, supports a Phase 1/Phase 2 open-label trial evaluating LMP744, a novel indenoisoquinolone c-Myc/topoisomerase 1 inhibitor, in patients with recurrent glioblastoma. This award carries no set-aside designation and represents the continuation of Medical Research Support LLC's established track record providing specialized clinical data management and research support to federal agencies.
Medical Research Support LLC, a sole proprietorship registered in the System for Award Management since February 2019, brings relevant expertise in clinical data management, database administration, and investigational new drug trial support. The company's prior work with the National Institutes of Health demonstrates proficiency in critical research functions including data entry, clinical database management, and adherence monitoring. This contract aligns with NINDS's mission to support research on neurological disorders and reflects the agency's investment in innovative therapeutic approaches for serious brain cancers such as glioblastoma.
Quick answers
Who was awarded contract 75N95A26P00038?
75N95A26P00038 was awarded to Medical Research Support LLC by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on February 6, 2026.
How much is contract 75N95A26P00038 worth?
The government has obligated $21,450 on 75N95A26P00038.
Was contract 75N95A26P00038 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award